|
| Study | Type of drug | Indication for drug therapy | time of drug exposure |
|
| Engroff and Kim (2007) [28] | PMT (x 1 case)
ZOL (x 1 case) | Brest Cancer (x 2 cases) | NR |
|
| Ferrari et al. (2008) [29] | PMT + ZOL | Multiple Myeloma | 21 mth (PMT)
3 mth (ZOL) discontinue therapy |
|
| Mücke et al. (2009) [30] | ZOL (x 2 cases) | Brest cancer (x 1 case);
Multiple Myeloma (x 1 case) | 50mth (ZOL)
36 mth (ZOL) |
|
| Nocini et al. (2009) [31] | PMT and ZOL (x 5 cases)
ZOL (x 2 cases) | Brest Cancer (x 5 cases);
Prostate Cancer (x 1 case);
Myeloid leukaemia and Osteoporosis (x 1 case) | NR |
|
| Seth et al. (2010) [32] | ZOL (x 6 cases)
ALD (x 2 cases)
IBA (x 2 cases)
ETI (x 1 case) | Brest Cancer (x 5 cases);
Prostate Cancer (x 2 cases);
Multiple Myeloma (x 2 cases);
Osteoporosis (x 2 cases) | NR |
|
| Bedogni et al. (2011) [33] | NR | NR | NR |
|
| Pautke et al. (2011) [34] | ZOL | Prostate Cancer | 40 mth |
|
| Bittner et al. (2012) [35] | ZOL and PMT | Pain syndrome | 12 mth (ZOL)
3 mth (PMT) |
|
| Ghazali et al. (2013) [36] | ALD | Osteoporosis | 84 mth (ALD) |
|
| Hanasono et al. (2013) [37] | ZOL (x 9 cases)
PMT (x 2 cases) | Multiple Myeloma (x 5 cases);
Breast Cancer (x 2 cases);
Prostate Cancer (x 2 cases);
Osteoporosis (x 2 cases) | NR |
|
| Horta et al. (2014) [38] | ZOL | Lung Cancer | 36 mth (ZOL) |
|
| Spinelli et al. (2014) [39] | ZOL (x 3 cases)
PMT (x 3 cases)
ZOL and PMT (x 2 cases) | Multiple Myeloma (x 4 cases);
Brest Cancer (x 3 cases);
Prostate Cancer (x 1 case) | 1 x 27 mth (ZOL)
1 x 21 mth (ZOL)
1 x 35 mth (ZOL
1 x 22 mth (PMT)
1 x 30 mth (PMT)
1 x 19 mth (PMT
1 x 25 mth (ZOL and PMT)
1 x 17 mth (ZOL and PMT) |
|
| Vercruysse et al. (2014) [25] | 1 x ZOL
1 x ZOL + PMT
1 x ZOL + CLO | Multiple Myeloma (x 2 case);
Brest Cancer (x 1 case) | 1 x 22mth (ZOL)
1x 12 mth (PMT) + 26 mth (ZOL)
1x 96 mth (CLO) + 29mth (ZOL) |
|
| Kim et al. (2015) [40] | ALD (x 2)
ALD + RSD + PMT (x 1)
ZOL + PMT (x 1) | Osteoporosis (x 3)
Multiple Myeloma (x 1) | 1 x 48 mth (ALD)
1 x 120 mth (ALD
1 x 24 mth (ALD + RSD +PMT)
1 x 30mth (ZOL +PMT) |
|
| Mücke et al. (2016) [41] | NR | NR | NR |
|
| Neto et al. (2016) [26] | ZOL | Lung Cancer | 36 mth (ZOL) |
|
| Sotsuka et al (2016) [42] | ZOL | Brest Cancer | 59 mth (ZOL) |
|
| Caldroney et al. (2017) [43] | 7 x ZOL
2 x ALD
1 x ZOL + DZM
1 x PMT + DZM | Brest Cancer (x 4 cases)
Osteoporosi (x 3 cases)
Multiple Myeloma (x 3 cases)
Prostate Cancer (x 1 case) | NR |
|
